Estee Lauder announced on Wednesday that it expects annual profits for the upcoming year to exceed previous market expectations. The cosmetics company attributed the forecast to sustained demand for luxury fragrances and a strong sales performance in China. Following the announcement, shares for the owner of Clinique and M.A.C rose nearly 7% in premarket trading.
The company's outlook follows a period of internal restructuring under CEO Stephane de La Faverie. The "Beauty Reimagined" strategy has focused on accelerating premium product launches, streamlining supply chains, and increasing investments in marketing and innovation. This follows the collapse of merger discussions with Jean Paul Gaultier-owner Puig in May.
For the fiscal 2026 fourth quarter, Estee Lauder reported sales of $3.63 billion, surpassing the $3.54 billion estimate. The company noted that demand for luxury skincare and fragrance brands, such as Le Labo and Balmain Beauty, remained resilient among affluent and younger consumers. Additionally, the company recorded a $38 million benefit in cost of sales from refunds during the quarter, which helped mitigate $102 million in incremental tariffs recorded throughout the full year.
The reported performance highlights a specific trend in consumer behavior where younger and wealthier shoppers continue to spend on "premium" or "luxury" items despite broader economic fluctuations. For these consumers, the primary notice will be an increase in product launches and marketing efforts as the company reinvests its earnings. The company also navigated significant trade costs, reporting $102 million in incremental tariffs over the year, a figure that represents the direct cost of international trade barriers on the firm's supply chain and bottom line.
Looking forward, the company's "Beauty Reimagined" strategy sets a precedent for how legacy luxury brands may attempt to streamline operations to offset tariff costs and shifting regional demands. The success of this strategy in the 2027 fiscal year will likely influence how competitors in the cosmetics and fragrance markets allocate their marketing and innovation budgets. Investors and industry analysts will monitor whether the projected earnings of $3.10 to $3.35 per share are met as the 2027 fiscal year progresses.